威高骨科
(688161)
| 流通市值：19.60亿 | | | 总市值：102.24亿 |
| 流通股本：7666.67万 | | | 总股本：4.00亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 347,912,613.72 | 1,283,549,219.69 | 1,082,526,944.91 | 805,385,247.36 |
| 营业收入 | 347,912,613.72 | 1,283,549,219.69 | 1,082,526,944.91 | 805,385,247.36 |
| 二、营业总成本 | 317,060,839.41 | 1,174,225,736.56 | 939,467,400.17 | 652,787,478.83 |
| 营业成本 | 141,056,807.61 | 429,703,688.01 | 345,169,334.39 | 231,212,796.35 |
| 税金及附加 | 3,124,704.18 | 18,528,212.62 | 15,438,208.46 | 11,566,788.3 |
| 销售费用 | 132,945,293.21 | 560,823,902.88 | 468,100,649.76 | 335,956,271.63 |
| 管理费用 | 16,539,976.16 | 60,991,061.92 | 42,312,824.49 | 26,781,167.46 |
| 研发费用 | 29,532,012.18 | 130,195,414.65 | 86,638,389.02 | 61,718,956.12 |
| 财务费用 | -6,137,953.93 | -26,016,543.52 | -18,192,005.95 | -14,448,501.03 |
| 其中:利息费用 | 159,416.85 | 945,769.88 | 308,781.69 | 273,311.4 |
| 其中:利息收入 | 5,821,610.48 | 28,421,870.17 | 17,549,494.83 | 14,698,697.64 |
| 加:公允价值变动收益 | - | 126,121 | - | - |
| 加:投资收益 | 6,465,333.11 | 27,690,444.2 | 20,722,028.29 | 13,611,884.02 |
| 资产处置收益 | -12,638.05 | 16,107.73 | 91,885.87 | 91,885.87 |
| 资产减值损失(新) | -186,557.83 | -30,766,130.78 | -39,351,890.66 | -39,269,686.69 |
| 信用减值损失(新) | 3,012,079.43 | 16,042,934.93 | 11,867,219.64 | 2,409,228.22 |
| 其他收益 | 1,403,597.89 | 8,458,798.39 | 6,013,587.72 | 4,476,483.82 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 41,533,588.86 | 130,891,758.6 | 142,402,375.6 | 133,917,563.77 |
| 加:营业外收入 | 95,487.51 | 1,235,296.26 | 726,396.28 | 293,253.06 |
| 减:营业外支出 | 151,566.67 | 503,569.35 | 197,163.21 | 169,217.71 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 41,477,509.7 | 131,623,485.51 | 142,931,608.67 | 134,041,599.12 |
| 减:所得税费用 | 5,625,726.47 | 18,530,911.52 | 21,054,484.12 | 22,543,934.29 |
| 六、净利润 | 35,851,783.23 | 113,092,573.99 | 121,877,124.55 | 111,497,664.83 |
| 持续经营净利润 | 35,851,783.23 | 113,092,573.99 | 121,877,124.55 | 111,497,664.83 |
| 归属于母公司股东的净利润 | 34,905,665.79 | 112,315,000.06 | 122,008,305.5 | 111,757,020.11 |
| 少数股东损益 | 946,117.44 | 777,573.93 | -131,180.95 | -259,355.28 |
| (一)基本每股收益 | 0.09 | 0.28 | 0.31 | 0.28 |
| (二)稀释每股收益 | 0.09 | 0.28 | 0.31 | 0.28 |
| 九、综合收益总额 | 35,851,783.23 | 113,092,573.99 | 121,877,124.55 | 111,497,664.83 |
| 归属于母公司股东的综合收益总额 | 34,905,665.79 | 112,315,000.06 | 122,008,305.5 | 111,757,020.11 |
| 归属于少数股东的综合收益总额 | 946,117.44 | 777,573.93 | -131,180.95 | -259,355.28 |
| 公告日期 | 2024-04-30 | 2024-03-27 | 2023-10-28 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |